Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Discovery Medicine|January 20, 2007
Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapyEdwin Bremer, Wijnand HelfrichMethods in Molecular Biology (Clifton, N.J.)|February 6, 2014
Bifunctional antibody fragment-based fusion proteins for the targeted elimination of pathogenic T-cell subsetsWijnand Helfrich, Edwin BremerFrontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
EpCAM-targeted induction of apoptosisEdwin Bremer, Wijnand HelfrichMethods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Development of Bispecific Antibody Derivatives for Cancer ImmunotherapyYuan He, Wijnand Helfrich, Edwin BremerCancer Letters|January 11, 2011
Antibody-based fusion proteins to target death receptors in cancerMarco de Bruyn, Edwin Bremer, Wijnand HelfrichCancers|August 12, 2023
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)TherapyIsabel Britsch, Anne Paulien van Wijngaarden, Wijnand HelfrichMedicinal Research Reviews|July 28, 2011
Therapeutic potential of Galectin-9 in human diseaseValerie R Wiersma, Marco de Bruyn, Wijnand Helfrich, et al.The Journal of Gene Medicine|August 5, 2014
Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL)Mohammad Arabpour, Klaas Poelstra, Wijnand Helfrich, et al.Frontiers in Oncology|March 10, 2015
The ever-expanding immunomodulatory role of calreticulin in cancer immunityMarco de Bruyn, Valerie R Wiersma, Wijnand Helfrich, et al.International Journal of Molecular Sciences|April 17, 2025
Enhancing the Anticancer Activity of a Carcinoma-Directed Peptide-HLA-I Fusion Protein by Armoring with Mutein IFNαDouwe Freerk Samplonius, Anne Paulien van Wijngaarden, Lisanne Koll, et al.Pageof 8